Not provided
Not provided
Not provided
Not provided
Not provided
COVID-19
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Medical Research Council | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
This study determines the effect of aerobic and resistance exercise training on whole-body and skeletal muscle insulin sensitivity in south Asians and evaluate the mechanisms which contribute to improvements in insulin sensitivity after exercise training.
South Asians (SA) have 2-4 fold higher risk of type 2 diabetes and develop the disease at lower body weights and younger ages than white Europeans. Lower cardiorespiratory fitness and capacity for muscle fat oxidation contributes substantially to SAs' greater insulin resistance, the extent to which this can be improved by exercise training is unclear. This randomised controlled trial will investigate the effects of a 12-week aerobic or resistance exercise training intervention on insulin sensitivity (hyperinsulinaemic-euglycaemic clamp) in South Asian adults (22 control, 22 aerobic exercise group and 22 resistance exercise group). The study will also explore the mechanisms within skeletal muscle which mediate these changes by evaluating aerobic and resistance exercise-training induced changes: in basal and insulin-stimulated microvascular blood volume (using contrast-enhanced ultrasound); skeletal muscle mitochondrial function; and lipid droplet morphology and spatial interaction with mitochrondria, muscle fibre capillarisation, endothelial content of key enzymes controlling dilation/constriction and GLUT-4 translocation (using confocal immunofluorescence microscopy and transmission electron microscopy methods). Thus, this work will integrate physiological and molecular data to determine the extent to which exercise training can improve insulin sensitivity in SA and the mechanisms underpinning this improvement. This knowledge is important for optimising diabetes prevention interventions in SAs and identification of potential novel therapeutic targets.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | No Intervention | Participants assigned to the control arm of the study will be asked to maintain their normal dietary and exercise habits. | |
| Aerobic exercise group | Experimental | Participants randomised to the aerobic exercise intervention will undertake a 12-week aerobic exercise training programme. |
|
| Resistance exercise group | Experimental | Participants randomised to the resistance exercise intervention will undertake a 12-week aerobic exercise training programme. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aerobic exercise programme | Behavioral | Participants will start with 3 x 20 minute exercise sessions in the first week, building up to 5 x 60 minutes of exercise by weeks 9-12 of the intervention, at an intensity of 65-80% of predicted maximum heart rate. |
| Measure | Description | Time Frame |
|---|---|---|
| Whole-body Insulin sensitivity | Change in whole-body insulin sensitivity measured by hyperinsulinaemic-euglycaemic clamp. | Change between baseline and 12 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| Insulin-stimulated GLUT4 translocation | Change in insulin-stimulated GLUT4 translocation in muscle biopsies from vastus lateralis using immunofluorescence microscopy | Change between baseline and 12 weeks. |
| Microvascular blood volume |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jason Gill, PhD | University of Glasgow | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Glasgow | Glasgow | G12 8QQ | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33159841 | Derived | Marx N, Davies MJ, Grant PJ, Mathieu C, Petrie JR, Cosentino F, Buse JB. Guideline recommendations and the positioning of newer drugs in type 2 diabetes care. Lancet Diabetes Endocrinol. 2021 Jan;9(1):46-52. doi: 10.1016/S2213-8587(20)30343-0. Epub 2020 Nov 4. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Randomised controlled trial
Not provided
Not provided
Masking is not possible due to nature of intervention (exercise training programme).
Not provided
| Resistance exercise programme | Behavioral | Participants will undertake two supervised sessions per week. The exercises performed during each session will consist of leg press, calf press, leg extension, leg curl, chest press, shoulder press, lateral pull down and seated row. Exercises will be performed at 60-80% 1RM. In weeks 1-2 participants will perform, during each session, a single set of 5-10 repetitions of each exercise (tiring but comfortably achievable) to ensure they are comfortable with the exercises and are performing these in the correct form. In weeks 3-4 participants will perform, during each session, two sets of each exercise to voluntary muscular failure - defined as not being able to perform single another repetition. In weeks 5-12 this will progress to 3 sets of each exercise to voluntary muscular failure, in each session. |
|
Change in fold-increase in insulin stimulated quadriceps muscle blood volume measured using contrast enhanced ultrasound.
| Change between baseline and 12 weeks. |
| Muscle mitochondrial function | Change in mitochondrial function (oxygen consumption rate) in isolated skeletal muscle mitochondria from the vastus lateralis measured using respirometry | Change between baseline and 12 weeks. |
| Lipid droplet content in skeletal muscle | Change in fibre type-specific (type 1 and type 2) and subcellular-specific (subsarcolemmal and intermyofibrillar) lipid droplet content in muscle biopsies from vastus lateralis using immunofluorescence microscopy | Change between baseline and 12 weeks. |
| Lipid droplet proximity to mitochondria in skeletal muscle | Change in proportion of lipid droplets in contact with mitochondria in subsarcolemmal and intermyofibrillar compartments of type 1 and type 2 muscle fibres in muscle biopsies from vastus lateralis using immunofluorescence microscopy | Change between baseline and 12 weeks. |
| Microvascular density in skeletal muscle | Change in fibre-type specific capillarisation in muscle biopsies from vastus lateralis | Change between baseline and 12 weeks. |
| Change in enzymes controlling insulin-mediated increases in perfusion in skeletal muscle | Change in endothelial specific protein content and phosphorylation of key microvascular enzymes in muscle biopsies from vastus lateralis assessed using quantitative immunofluorescence. | Change between baseline and 12 weeks. |
| Maximal oxygen uptake | Change in maximal oxygen uptake consumption assessed using continuous incremental uphill walking protocol until volitional exhaustion. | Change between baseline and 12 weeks. |
| Muscle maximal voluntary contraction | Change in knee extensor muscles maximal voluntary contraction | Change between baseline and 12 weeks. |
| Lower body muscle strength | Change in 1-RM (one maximal repetition) (kg) for leg press. | Change between baseline and 12 weeks. |
| Upper body muscle strength | Change in 1-RM (one maximal repetition) (kg) for chest press. | Change between baseline and 12 weeks. |
| Grip strength | Change in grip strength (kg). | Change between baseline and 12 weeks. |
| Fat mass | Change in fat mass measured with bioelectrical impedance analysis (BIA). | Change between baseline and 12 weeks. |
| Fat-free mass | Change in fat-free mass measured with bioelectrical impedance analysis (BIA). | Change between baseline and 12 weeks. |
| Weight | Change in weight (kg). | Change between baseline and 12 weeks. |
| Waist circumference | Change in waist circumference (cm) | Change between baseline and 12 weeks. |